Since 2004 the Resource Tracking for HIV Prevention Research and Development Working Group (“Working Group”) has employed a comprehensive methodology to track trends in research and development (R&D) investments and expenditures for biomedical AIDS prevention options, including:
- AIDS vaccines
- Pre-exposure prophylaxis (PrEP)
- Treatment as prevention (TasP)
- Voluntary medical male circumcision (VMMC)
- Female condoms
- Prevention of vertical transmission (PMTCT)
The Working Group also tracks investments toward HIV cure research which, under the National Institutes of Health (NIH) Office of AIDS Research (OAR) definition include investments in therapeutic AIDS vaccines.
Click on the links for much more information.